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Disclaimer
The views expressed in this article are those of the author(s) and 
do not reflect those of their employers or institutions. Publica-
tion in Wellcome Open Research does not imply endorsement 
by Wellcome.
Introduction
COVID-19 is caused by a novel beta-coronavirus named severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
that was first reported in December 2019 in the city of 
Wuhan, Hubei province, China1. SARS-CoV-2 infection has 
quickly spread across the globe2, with the first case reported 
on the African continent, in Egypt on February 14th 20203. 
COVID-19 was declared a public health emergency of inter-
national concern by the World Health Organization (WHO) 
on March 11th 20204. Just a few months into the pandemic, 
COVID-19 has ravaged developed countries, with significant 
case fatality rates in Europe and the USA5. Considering the large 
number of people that live in poor and crowded informal set-
tings in sub-Saharan Africa (SSA)6,7, the mode of transmission 
of SARS-CoV-2, the severity of the disease as well as the exist-
ing fragile health systems8–10 it was hypothesized that Africa 
may markedly be affected by the COVID-19 pandemic result-
ing in disastrous consequences with a large number of patients 
overwhelming hospitals and high case fatality rates8,11.
As of June 6th COVID-19 global infections recorded in 215 
countries were 6,663,034 cases and 392,802 deaths [5.9%]. 
The three countries with the highest burden were the USA with 
1,857,872 cases [deaths 5.8%], Brazil 614,941 [5.5%] and 
Russia 458,689 [1.2%]. Italy and Spain were highly affected in the 
first quarter of the year but have stabilised their epidemics since 
the beginning of May 2020 with 234,531 cases [deaths: 14.4%] 
and 240,978 [11.3%] respectively5. At the same time, the African 
continent accounted for only 2.6% of the global infections with 
177,953 cases and 4,936 deaths [2.8%] in 54 countries12. Four 
African countries, South Africa, Egypt, Morocco and Algeria, 
comprise more than 52% of reported COVID-19 cases in Africa12 
and only one of these countries is located in the SSA region. 
Although the global number of SARS-CoV-2 infections increased 
exponentially since the beginning of the pandemic due to ongo-
ing transmission, the low number of infections and deaths 
recorded in SSA countries have raised suspicions on whether they 
represent a slow progression of the pandemic in Africa, a lower 
case fatality rate, or simply a lack of testing or reliable data. 
Notably, there is no significant  increase in unexplained pneu-
monias or deaths recorded on the continent which could possibly 
indicate the effectiveness of interventions introduced by sev-
eral African governments. However, there has not yet been a 
comprehensive assessment of SSA’s preparedness and response 
to the COVID-19 pandemic that may have contributed to prevent 
an uncontrolled outbreak so far.
Here, we – a diverse group of early career researchers (grad-
uate students and post-doctoral scientists) and the next 
generation of African scientific leaders with experience working 
in various fields of health research including medicine, immu-
nology, molecular biology, microbiology, virology and public 
health in both SSA countries and in developed countries – con-
ducted an assessment of African preparedness and response to 
the COVID-19 during the early (first 3 months) of the pan-
demic on the African continent. The early career research-
ers involved are fellows of the African Academy of Science’s 
Sub-Saharan African Network for TB/HIV Research Excel-
lence (SANTHE)13, (part of the DELTAS Africa initiative) and 
some were at the frontline of the battle against COVID-19 in 
their respective countries during the time of this assessment.
As of June 6th 2020, the seven countries represented had 
reported the following caseloads of COVID-19: Cameroon, 
7,599 cases [deaths: 2.8%]; Kenya, 2,600 [3.2%]; Zambia, 1,089 
[0.6%]; Rwanda, 431 [0.5%]; Uganda, 593 [0%]; Botswana, 
40 [2.5%];12 and South Africa, which had recorded the highest 
number of COVID-19 cases in Africa with 45,973 cases [2.1% 
deaths]12. Even though the COVID-19 pandemic unfolded rap-
idly, and the undertaken public health measures interrupted our 
studies, our careers and other usual activities, this pandemic 
has also offered a blueprint on how to deal with epidemics. 
This analysis presents a unique perspective on the currently 
developed public health interventions to fight COVID-19 
on the African continent. We discuss the challenges and oppor-
tunities that exist to improve African capacity to fight future epi-
demics from our perspective as the next generation of scientists 
that will oversee these responses in the future.
Our evaluation of sub-Saharan Africa preparedness and response 
to COVID-19 reviewed country specific preventive meas-
ures and critically examined the response to the pandemic in 
seven African countries. We assessed the public health meas-
ures and other crucial interventions that were put in place in 
the control of COVID-19 in Uganda, Kenya, Rwanda, Cameroon, 
Zambia, South Africa and Botswana. We argue that these strate-
gies may have helped to prevent a disastrous outcome by reduc-
ing rapid transmissions that may happen in clusters and mini-
mizing the number of patients seeking medical assistance at 
the same time. We also identified and summarized in three cat-
egories of biomedical, sociocultural and economic factors; the 
challenges encountered at different levels of the health system. 
We presented the gaps existing in the public health interven-
tion programs that may result in delays/failure to halt the spread 
of the disease as well as the important components of disease 
control that may strengthen sub-Saharan Africa preparedness 
and response to future outbreaks.
Assessment and findings
The rapid rise of SARS-CoV-2 infections sent a clear message 
to the world that quick action was needed to prevent the spread 
of the disease. WHO warned on February 22nd 2020 that all 
member states of the African Union should develop an early 
strong plan of action to tackle the growing threat14. As emerging 
Africa leaders in health research and fellows of the SANTHE 
consortium, we convened a virtual meeting to discuss the 
threat that the pandemic posed to SSA and agreed that we had 
a responsibility to critically analyze the response of our govern-
ments so far and to offer our own perspective on how this and 
other similar epidemics should be tackled on the continent. 
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In the meeting, participants discussed the origin of the new 
SARS-CoV-2 virus, infection preventive measures, diagnostic 
tests, clinical management of the disease and the development 
of vaccines and therapeutics by critically reviewing the available 
scientific literature. We discussed the need for scientific and 
evidence-based responses that considered Africa’s unique health-
care, sociocultural and economic challenges. We therefore 
decided to review SARS-CoV-2 infection dynamics in Africa 
and the responses that African governments were taking, 
relying primarily on published scientific articles, publicly 
available government technical reports, media announcements 
and our own personal experiences and perspectives. Consid-
ering that the response to the epidemic has been very vari-
able from country to country, we agreed to focus our analysis 
from reports emanating from Uganda, Kenya, Rwanda, 
Cameroon, Zambia, South Africa and Botswana, countries that 
were represented among us. An extensive review of the steps 
taken in preparedness and response to COVID-19 guided by 
a representative from each of the seven SSA countries was 
conducted and a conclusive report encompassing our perspectives 
was generated.
Sub-Saharan Africa preparedness for COVID-19
Since the beginning of the COVID-19 pandemic, the world’s top 
priority was to contain the spread of SARS-CoV-2, to reduce 
disease fatalities and to limit the patient burden on health sys-
tems. Despite the uncertainty and unanswered questions around 
the management of the newly emergent SARS-CoV-2 infec-
tion, African countries joined the global effort to battle the 
COVID-19 pandemic as we outline in detail below. It has 
been reported that the experiences of SSA countries in han-
dling ongoing outbreaks and managing infectious diseases such 
as Ebola, tuberculosis, malaria and HIV came in handy in the 
fight of COVID-1915–17. Pre-existing emergency plans on public 
health interventions, community engagement programs and the 
work force composed of emergency medical experts and 
trained health care workers were quickly re-directed to ensure 
a fast response to COVID-1915–19.
As early as January 2020, prior to the identification of the 
first case of SARS-CoV-2 infection on the African continent 
on February 14th 20203, African countries had already initi-
ated public engagement conversations to inform the population 
about the new pandemic20–26. Public notices about COVID-19 
were issued between January and March in the seven SSA coun-
tries that we assessed27–33. In preparation for possible incom-
ing cases the Ministries of Health worked with local health 
authorities to designate medical teams, testing laboratories 
and clinical facilities for isolation and care of COVID-19 
patients23,34–39. Through media communication, health authorities 
addressed the new threat, communicating the signs and symp-
toms of SARS-CoV-2 infection, its mode of transmission as 
well as the preventive measures and safety guidelines such as 
hand and respiratory hygiene and social distancing according 
to WHO guidelines and recommendations22,40–46. Some of the 
countries that were considered in this analysis such as Rwanda 
and Kenya quickly instituted widespread hand washing 
stations or used hand sanitizers in public places such as bus 
stations and restaurant entrances47–49. Health communication 
about COVID-19 was made easier by the use of social media 
platforms such as WhatsApp, Facebook or Twitter, whereas 
web-based chat or a hotline number that could be contacted for 
information and inquiries about COVID-19 were made avail-
able to the public in all the seven countries21,26,50–55. Furthermore, 
in an effort guided by Africa CDC to strengthen the emergency 
response to COVID-19, the readiness of African countries to 
handle the new disease was assessed and training of health care 
workers and lab technologists on diagnosis and management 
of SARS-CoV-2 infection was conducted20.
The majority of African countries lack specialized medical 
capacity that is critical for handling severe cases of COVID-
19, such as intensive care unit (ICU) beds10,56 and mechanical 
ventilators57. Therefore, the main priority on the African con-
tinent was to contain the infection, initiate immediate testing 
for suspected cases and to start medical intervention prior to 
development or progression to severe clinical disease. The coun-
tries we assessed focused their efforts on prevention, early 
identification of new infections and mitigating mass spread of 
the virus by quickly tracing case contacts based on the avail-
able information. All seven countries initiated border screening 
at ports of entry by March 2020 and a 14-day self-quarantine 
was recommended for all incoming travellers51,58–63.
Although as a result of few or unavailable laboratory technol-
ogy, some SSA countries could not test for COVID-19 locally, 
the early established collaborative model among African 
countries, coordinated by the Africa CDC, increased testing 
capacity across the continent20,64,65 as an example early sam-
ples of suspected COVID-19 cases from the Central African 
Republic were shipped to Rwanda for testing until the local 
capacity became available. Nonetheless, testing constraints still 
remain in most countries66, and therefore testing priority was 
given to most at risk persons such as returning travellers, or the 
people who have been in contact with confirmed cases, iden-
tified through contact tracing by health care workers. All the 
seven countries have initiated early testing of suspected cases 
and established designated facilities for testing and clinical care 
of COVID-19 patients28,34–39.
Sub-Saharan Africa response to COVID-19
The early implementation of COVID-19 preventive meas-
ures delayed the rapid spread of the virus within the African 
population, but these procedures could not completely halt 
the spread of the virus in all seven countries. Soon after 
each country had identified the first case of COVID-19, new 
infections were reported, with the majority related to returnee 
travellers or contacts of index COVID-19 cases. To reduce 
the risk of imported cases, these countries, with the excep-
tion of Zambia, swiftly closed borders, shut airports and 
reduced incoming travellers to essential workers and returning 
residents25,60–63,67–70. In order to mitigate further spread of the 
disease, individuals diagnosed with COVID-19 were admit-
ted in designated isolation areas for care and medical assist-
ance while case contact tracing was immediately initiated. 
Additionally, mass gatherings and non-essential travels were 
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prohibited, government and private business staff were encour-
aged to work from home and schools were closed63,69–75. With the 
exception of Zambia, the assessed SSA countries implemented 
a dusk to dawn curfew and nation-wide lockdown to enforce 
social distancing measures, limiting movements to essential 
service providers69,76–81. These measures were mainly put in place 
to prevent large volumes of new infections that would result 
in a high demand for hospital services, potentially leading to 
overwhelming of the fragile medical infrastructure82,83.
Contrary to what was initially expected, the spread of SARS-
CoV-2 has been relatively slower in Africa11, and COVID-
19 infections have been generally mild to moderate, leading 
to more recoveries and lower fatality rates in the seven SSA 
countries84 compared to Western countries5. It should also be 
mentioned that this pandemic started earlier on the other con-
tinents, suggesting that it may be too early for SSA to cel-
ebrate its relative success as Africa may have not yet faced the 
highest phase of the disease. However, a comparison of the 
early phases of the pandemic in some African and European 
countries has shown a positive impact of early interventions ini-
tiated by SSA countries resulting in distinct disease trajecto-
ries, For example a comparison of the infection dynamics in 
the United States, United Kingdom, Italy and Spain vs South 
Africa and Cameroon has shown a continual exponential peak 
in non-African countries but slow and gradual increase in both 
of the SSA countries85.
Our analysis suggests that early initiation of preventive meas-
ures, a faster response by timely testing of suspected cases and 
immediate contact tracing done by SSA countries has mitigated 
a faster and more extensive spread of the virus in the popula-
tion. Additionally, a contemporary warm climate may have 
impacted the dynamics of the SARS-CoV-2 transmission in 
these countries86–88. We posit that the predominantly young 
demography could be a contributing factor to a mild dis-
ease and low case fatality observed in Africa18,89. Furthermore, 
there are suggestions that cross reactive-immunity result-
ing from previous infections that are predominant in the region 
or the universal BCG vaccine policy90, widely recommended 
for infants vaccination in the assessed countries, may have 
offered some health benefits such as enhanced lung cells immu-
nity against infections contributing to better clinical outcome of 
the disease. However, these observations have not yet been con-
firmed by rigorous evaluations. Altogether, the prevention pro-
grams that were put in place and the early response implemented 
by SSA countries may have mitigated the widespread dissemi-
nation of the SARS-CoV-2 virus and fatality due to COVID-
19 in SSA countries67,91. The interventions implemented in all 
seven SSA for prevention and control of the COVID-19 are 
summarized in Table 1.
Biomedical, sociocultural and economic challenges met in 
the course of COVID-19 pandemic
The ability to coordinate a rapid response to COVID-19 by 
African governments, guided by health and scientific experts in 
the assessed countries, has shown the continent’s strengths and the 
expertise to tackle health threats like the COVID-19. However, 
the main challenges in SSA countries such as poor infrastructure92, 
clusters of high density populations93, highest global bur-
den of infectious diseases94, and low GDP per capita95,96 
have impacted the sustainability of these interventions resulting 
in early ease of the key measures to prevent other consequences 
unrelated to the pandemic. Details about the key challenges 
are summarized in Table 2.
The main challenges that Africa faces in the response to 
COVID-19 pertain to lack of local biotechnological produc-
tion and limited research capacity or expertise in speciality 
fields, thus making African countries unable to conduct suf-
ficient testing and focused research studies related to disease 
transmissibility, vaccine or cure research relevant to the local 
context. Many African countries are relying on equipment 
and reagents imported from outside the continent. Although, 
most African countries already have the equipment footprint 
for COVID-19 tests from the key manufacturers Abbott, 
Cepheid and Roche, testing capacity is hindered by the ina-
bility to rapidly expand the technological capacity, limited 
funds and more recently by the export restrictions imposed on 
COVID-19-related supplies97. It is heartening to note that countries 
such as Senegal and South Africa have initiated programmes to 
locally develop reagents and PPE98–100. The shift in focus to pro-
duction of COVID-19-specific items threatens the pre-existing 
line products needed for other infections such as HIV and TB. 
For example procurement of COVID-19 supplies has ham-
pered the existing unstable supply chain for routine medical 
supplies that are essential for the management of other medi-
cal conditions (e.g. antiretroviral therapy, tuberculosis and 
hepatitis drugs, infant vaccines, anesthesia needed for surger-
ies and dental treatments, test kits, laboratory reagents and 
consumables used for other medical/research activities).
The mode of transmission of SARS-CoV-2 has led to enforce-
ment of social distancing measures by restrictions of mass gath-
erings and a national lockdown in six of the seven countries 
that we assessed60–63,69,70,72–75. This method of prevention has 
specifically disrupted the school programmes and created eco-
nomic crises that resulted in hunger101 and other hardships 
for the large SSA population who depend on casual labor and 
rely on daily income6. The fragile health systems coupled 
with lockdown measures have inadvertently reduced access to 
health care for non-emergency and other pre-existing medi-
cal conditions. For example with a re-prioritisation of human 
resources, it is estimated that an additional 6.5 million TB 
cases will occur over the next five years102. Although the impact 
on other diseases such as HIV and malaria has not been 
assessed, it is likely that the COVID-19 pandemic will set back 
some of the gains made in the countries’ responses to these 
killer diseases.
Recommended solutions to bridge the gaps for improved 
outbreak preparedness and response
Based on our assessment of the challenges and the gaps that 
were found in the approach used by the seven SSA to prevent/
respond to COVID-19 outbreak, we summarized the potential 
solutions in Figure 1. We classified these into three interconnected 
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Table 1. Summary of interventions implemented for prevention and response to COVID-19.
Preparedness and preventive measures (January- March 2020)
Strengthening 
medical capacity and 
testing technology.
In collaboration with WHO, Africa CDC and member states the following steps were taken: 
•    January 27th: Africa CDC activated its emergency operations center incident Management system (IMS) for the 2019 n-CoV outbreak. 
•    Procurement of SARS-CoV-2 testing kits 
•    Establishment of collaborative model among African countries, setting up a specimen referral system. 
•    Deployment of health experts, training and technical support of staff from risky areas such as airports. 
•    Development of informational materials on the infection. 
•    Development/strengthening capacity of local health facilities. 
•    Timely communication and weekly updates on high priority areas for coronavirus control. 
•    Avail scientiic documentation and references on the new coronavirus. 
•    Ministries of Health and authorities from all seven countries designated a medical team and indicated health facilities for testing and clinical care of 
COVID-19 patients.
Public engagement 
and Educational 
Sessions
•    Health authorities issued public information regarding the new disease, signs and symptoms, health precautions and communicated the WHO/
country speciic safety guidelines. 
•    Each country issued an oficial communication independently on different days as shown below: 
Kenya South Africa Cameroon Rwanda Botswana Uganda Zambia
February 2nd March 7th January 28th January 21st March 16th March 2nd March 25th
•    Rwanda and Kenya instituted widespread hand washing stations and used hand sanitizers in public places such as bus stations and restaurant 
entrances. 
•    Mass media use for awareness and health promotion. 
•    Social media technology facilitated communication about COVID-19 between health care workers and the public. 
•    Each country issued a hotline number speciic for COVID-19 information/response.
Training health care 
workers and lab 
technologists
•    February 6–7th effort guided by Africa CDC for Strengthening the emergence response to COVID-19 by training African laboratories and clinicians on 
diagnosis and management of SARS-CoV-2 infection was conducted. 
•    Upon training completion, documentation about the critical steps of the management of SARS-CoV-2 infection developed by health authorities in 
each country was made available to health care workers and posted on the oficial website.
February 14th, 2020: First case of COVID-19 reported on the African continent (Egypt)
March 11th, 2020: WHO declares COVID-19 a Public health emergency of International concern
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Preparedness and preventive measures (January- March 2020)
Responsive measures (April-May 2020)
All the seven sub-Saharan African countries implemented similar responses to COVID-19 except Zambia that didn’t close borders or enforce a national lockdown. The different 
interventions and the date the implementation date in each country are presented below: 
1. Border closure for non-citizen and non-essential workers. (Except for Zambia)
2. COVID-19 screening at port of entry for all seven countries
3. 14-dayself-quarantine recommended for all incoming travellers.
4. Isolation of COVID-19 patients at designated facilities and close medical monitoring
5. Immediate contact tracing and testing.
6. Prohibit mass gathering and non-essential travels inside the country
7. Recommendation to work from home for private and government institutions
8. Schools closure
9. Dusk to dawn curfew and a national lockdown (Except Zambia)
Country Kenya South Africa Cameroon Rwanda Botswana Uganda Zambia
First positive case March 12th March 5th March 6th March 14th March 30th March 
21st
March 18th
1–3 March 15th March 16th March 18th March 3rd March 24th March 
22nd
February 21st
6–8 March 15th March 15th March 18th March 21st March 16th March 
25th
March 26th
9 March 28th 
April 6th
March 27th March 18th March 28th April 2nd March 
30th
Not done
Note1: Only screening at the port of entry and self-quarantine were implemented in Zambia. 
Note2: A curfew was irst implemented in Kenya in March 28th followed by a national lockdown in April 6th 2020
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Table 2. Biomedical, Sociocultural and economic challenges of outbreak control.
CATEGORY Type of challenge encountered Consequences on both preparedness and response to COVID-19 pandemic
Biomedical
Limited capacity for epidemiological techniques such as mathematical 
modeling to guide the decision making in response to the outbreak, 
particularly in localised settings.
•    Insuficient scientiic references to guide the response to the outbreak. 
Insuficient medical infrastructure including laboratory technology, 
(Example: RT-PCR testing labs)/medical capacity such as ICU services, 
mechanical ventilators.
•    Inability/reduced capacity to perform the required tests locally 
•    Delays in availability of test results 
•    Reduced patient safety that may result in life losses due to unavailability of 
required medical procedures. 
Shortage of medical supplies and PPE (priority given to COVID-19 medical 
and research activities)
•    Increased risk of infections among health care workers 
•    Interruption/delay of non-COVID-19 related research activities.
Insuficient testing capacity •    Inability to attain the testing level needed for adequate disease surveillance and 
control. 
•    Delayed testing that may result in increased disease spread due to late 
detection of COVID-19 cases.
Shortage of medical/research and clinical laboratory personnel and space •    Overworked medical personnel 
•    Focused medical attention to COVID-19 delaying non-essential medical services 
during the pandemic such as the recommended regular medical check-ups and 
non-life-threatening interventions. 
•    Interruption or delay of non-COVID-19 related medical/research activities 
(Example: minor/elective surgeries). 
Lack of local biotech capacity to conduct advanced biomedical research 
studies such as transmissibility of SARS-CoV-2 in the African climate 
conditions, antibody-based therapy, or vaccine and treatment research in 
the African population.
•    Relying on responses from countries that have the capacity to create solutions. 
•    Unavailability of accurate information relevant to the local context that is 
important for development of adequate preventive measures.
Sociocultural
Interruption of school programs and unavailability of remote education 
technology
•    Delays in completion of school programs 
Structure of the markets, social aspect of the population and the culture •    Dificulties to practice social distancing in the communities 
Science is misunderstood, suspicion of harmful and unethical 
interventions, misleading myths and faith-related rumors.
•    Mistrust of health care systems 
•    Failure to comply with safety procedures
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CATEGORY Type of challenge encountered Consequences on both preparedness and response to COVID-19 pandemic
Economic
Insuficient funds •    Limited procurement capacity, 
•    Dificulty to expand existing services or scale up to new available technology.
Borders closure and reduced frequency of international trade •    Delay of transport of essential materials that are initially imported (Example 
shortage of infant vaccines, anesthesia used for minor surgeries or dentistry). 
•    Increased cost for medical supplies and imported food items 
•    Unavailability of needed materials locally 
Interrupted supply chain due to market scarcity/ priority given to non- 
African countries
•    Incapacity to obtain suppliers for the African market even when there are 
available funds. 
•    Shortage of frequently used reagents that need to be imported.
Poor infrastructure, poverty, informal housing and high population density •    Increased risk to get the infection due to unavailability of essential sanitary 
services 
•    Nearly impossible to comply with social distancing 
•    Hardly able implement safety measures
Reduced job security due to lockdown measures •    Increased unemployment during COVID-19 pandemic 
•    Loss of income for most of the families who depend on casual labor, informal 
market that have been severely affected by the lockdown.
Lockdown resulting in reduced movements between cities, unavailability 
of public transportation and discontinued non-essential work activities 
including stopping work for researchers working on non COVID-19 
projects
•    Interruption of pre-existing programs (Ex: HIV prevention programs such 
as PrEP, ART treatment, TB programs, cancer, maternal health care or non-life-
threatening surgeries), 
•    Ironically, the emergence of a new virus has prevented virologists to go to the 
lab!
Lack of income due to discontinued earning activities, inability to buy food 
leading to starvation
•    Countries unplanned mobilization of emergency fund to feed poor families. 
•    Early ease of the lockdown that may result in new infections 
•    Re-opening work activities to avoid hunger related deaths.
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categories of biomedical, sociocultural and economic aspects 
that we recommended to help improve the preparedness and 
response to future outbreaks.
In response to the current COVID-19 pandemic, Africa CDC 
has started planning for the coordination of a centralised pro-
curement system to reach the target of 55 million tests across 
the continent. Tens of thousands of test kits, PPE and ther-
mometers have already been distributed to countries through a 
donation from the Jack Ma Foundation97. However, sustain-
ability of a strong supply chain requires African governments 
to mobilize resources and to avail funding for health emergency 
response and research development on the continent includ-
ing funded education in speciality fields. This will allow the 
countries to generate adequate interventions and to maintain 
a rapid response to outbreaks without overreliance on exper-
tise from non-African countries and urgent importation of sup-
plies. SSA countries should leverage novel medical/research 
capacity upon the existing structures that were put in place 
over many decades of fighting other public health threats such 
as Ebola, HIV, TB and malaria. The establishment of a net-
work of multidisciplinary health care workers competent in 
various tasks such as community education and testing, in a 
multi-disease focused approach would allow management of staff 
shortage rather than having to prioritize the new life-threatening 
disease over those that were already prevailing on the 
continent.
Limitations
Some of the limitations encountered during the development 
of this assessment were mainly related to the lack of sufficient 
documentation to address the actual reality in SSA countries, 
such as the status of health systems or informal housing structure. 
Documentation on physical capacity on the African ground is 
needed. Some essential documents lacked the important infor-
mation such as the date signed and released. Improvement on 
good record keeping especially for health data of this kind 
is essential for future references.
Our assessment was not designed to demonstrate with certi-
tude that the implemented interventions were directly linked to 
the number of infections or COVID-19 deaths in the assessed 
SSA countries. Clinical and biomedical research studies 
may be more appropriate to confirm these observations. Further, 
systematic reviews of effects would be informative. Neverthe-
less, we believe that our unique perspective on the SSA countries 
Figure 1. Recommended solutions for improved preparedness and response to future outbreaks.
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preparedness and response to a great health threat such as the 
COVID-19 pandemic has provided a valuable contribution 
to the future interventions.
Conclusion
We assessed the Sub-Saharan Africa preparedness and response 
to COVID-19. Based on an extensive review of the avail-
able scientific publications, the government technical reports 
and the announcements released by governmental and non-
governmental health organizations as well as our personal 
experiences as workers on the COVID-19 battlefield in SSA 
countries. We documented the preventive measures and the 
response put in place to contain the SARS-CoV-2 in seven 
SSA countries including Uganda, Kenya, Rwanda, Cameroon, 
Zambia, South Africa and Botswana. We have shown the 
strengths of early initiated interventions that may have contrib-
uted to modest and slower dynamics of COVID-19 in SSA coun-
tries. We discussed the need for scientific and evidence-based 
responses that considered Africa’s unique healthcare, sociocul-
tural and economic challenges. While efforts to bridge some of 
the gaps have been initiated, we recommend that SSA countries 
develop continued funding streams to support these initiatives 
as well to increase south to south/north- south collabora-
tions to enhance the capacity of the existing health systems. 
Therefore, if these problems are addressed in a timely manner, 
there is no doubt that in the next five years SSA countries will 
have developed a reliable-strong health system to prevent the 
newly emerging viral infections to spread at a large scale.
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